Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Capital Analysts LLC cut its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 291 shares of the biopharmaceutical company’s stock after selling 23 shares during the quarter. Capital Analysts LLC’s […]
Heritage Wealth Advisors decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 15.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 111 shares of the biopharmaceutical company’s stock after selling 20 shares during the quarter. Heritage […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Immune Therapeutics (OTCMKTS:IMUN – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Profitability This table compares Regeneron Pharmaceuticals and Immune […]
Intellectus Partners LLC lifted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,877 shares of the biopharmaceutical company’s stock after purchasing an additional 22 shares during the period. […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 1,270,000 shares, an increase of 17.6% from the June 30th total of 1,080,000 shares. Based on an average daily volume of 631,800 shares, […]